Adalimumab BS subcutaneous injection 40 mg pen 0.4 mL “MA”

Adalimumab BS subcutaneous injection 40 mg pen 0.4 mL “MA”, manufactured by Mochida Pharmaceutical, contains Adalimumab (genetical recombination) [Adalimumab follow-on 3]. Adalimumab is a TNF inhibitor used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. It is supplied as a 40mg/0.4mL/1 kit injectable drug (YJ code: 3999463G4024).